These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1958491)

  • 1. Treatment of Diamond-Blackfan anaemia with haematopoietic growth factors, granulocyte-macrophage colony stimulating factor and interleukin 3: sustained remissions following IL-3.
    Dunbar CE; Smith DA; Kimball J; Garrison L; Nienhuis AW; Young NS
    Br J Haematol; 1991 Oct; 79(2):316-21. PubMed ID: 1958491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
    Sieff C; Guinan E
    Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of recombinant human interleukin-3 therapy to induce erythropoiesis in patients with refractory Diamond-Blackfan anemia.
    Olivieri NF; Feig SA; Valentino L; Berriman AM; Shore R; Freedman MH
    Blood; 1994 May; 83(9):2444-50. PubMed ID: 8167334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open phase I study to assess the biological effects of a continuous intravenous infusion of Interleukin-3 followed by Granulocyte Macrophage-Colony Stimulating Factor.
    Bretti S; Gilleece MH; Kamthan A; Fitzsimmons L; Hicks F; Rowlands M; Bishop P; Picardo AM; Dexter TM; Scarffe JH
    Eur J Cancer; 1996 Jun; 32A(7):1171-8. PubMed ID: 8758249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM-CSF in the treatment of Fanconi's anaemia.
    Kemahli S; Canatan D; Uysal Z; Akar N; Cin S; Arcasoy A
    Br J Haematol; 1994 Aug; 87(4):871-2. PubMed ID: 7986733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
    Kurzrock R; Talpaz M; Gutterman JU
    Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for interleukin-3 in Diamond-Blackfan anaemia? Results of a European multicentre study.
    Ball SE; Tchernia G; Wranne L; Bastion Y; Bekassy NA; Bordigoni P; Debré M; Elinder G; Kamps WA; Lanning M
    Br J Haematol; 1995 Oct; 91(2):313-8. PubMed ID: 8547067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
    Vose JM; Pandite AN; Beveridge RA; Geller RB; Schuster MW; Anderson JE; LeMaistre CF; Ahmed T; Granena A; Keating A; Fernandez Ranada JM; Stiff PJ; Tabbara I; Longo W; Copelan EA; Nichols C; Smith A; Topolsky DL; Bierman PJ; Lebsack ME; Lange M; Garrison L
    J Clin Oncol; 1997 Apr; 15(4):1617-23. PubMed ID: 9193361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of human flt-3 ligand on committed progenitor cell production from normal, aplastic anaemia and Diamond-Blackfan anaemia bone marrow.
    Scopes J; Daly S; Ball SE; McGuckin CP; Gordon-Smith EC; Gibson FM
    Br J Haematol; 1995 Nov; 91(3):544-50. PubMed ID: 8555052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia.
    Guinan EC; Lopez KD; Huhn RD; Felser JM; Nathan DG
    J Pediatr; 1994 Jan; 124(1):144-50. PubMed ID: 8283365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma.
    Vadhan-Raj S; Papadopoulos NE; Burgess MA; Linke KA; Patel SR; Hays C; Arcenas A; Plager C; Kudelka AP; Hittelman WN
    J Clin Oncol; 1994 Apr; 12(4):715-24. PubMed ID: 8151315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo recruitment of GM-CSF-response myelopoietic progenitor cells by interleukin-3 in aplastic anemia.
    Herrmann F; Lindemann A; Raghavachar A; Heimpel H; Mertelsmann R
    Leukemia; 1990 Oct; 4(10):671-2. PubMed ID: 2214870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy.
    Sosman JA; Stiff PJ; Bayer RA; Peliska J; Peace DJ; Loutfi S; Stock W; Oldenburg D; Unverzagt K; Bender J
    Bone Marrow Transplant; 1995 Nov; 16(5):655-61. PubMed ID: 8547862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diamond-Blackfan Anaemia: an overview.
    Dianzani I; Garelli E; Ramenghi U
    Paediatr Drugs; 2000; 2(5):345-55. PubMed ID: 11022796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilization of peripheral blood stem cells by subcutaneous injections of yeast-derived granulocyte macrophage colony stimulating factor: a phase I-II study.
    Mangan K; Mullaney M; Klumpp T; Goldberg S; Macdonald J
    Stem Cells; 1993 Sep; 11(5):445-54. PubMed ID: 8241955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes.
    Nand S; Sosman J; Godwin JE; Fisher RI
    Blood; 1994 Jan; 83(2):357-60. PubMed ID: 8286736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M-07e cell bioassay detects stromal cell production of granulocyte-macrophage colony stimulating factor and stem cell factor in normal and in Diamond-Blackfan anemia bone marrow.
    Bonsi L; Bagnara GP; Strippoli P; Bonifazi F; Vitale L; Bonafè M; Santucci MA; Pinto L; Rosito P; Pession A
    Stem Cells; 1993 Jul; 11 Suppl 2():131-4. PubMed ID: 7691319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.